BVF Inc’s Mirum Pharmaceuticals MIRM Stock Holding History

BVF Inc’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$146M	Buy	1,584,727 +89,437	+6%	+$8.41M	4.66%	6
2025 Q4	$118M	Hold	1,495,290	–	–	3.98%	6
2025 Q3	$110M	Sell	1,495,290 -1,266,043	-46%	-$80.5M	4.44%	7
2025 Q2	$141M	Sell	2,761,333 -35,180	-1%	-$1.57M	5.02%	6
2025 Q1	$126M	Hold	2,796,513	–	–	5.13%	5
2024 Q4	$116M	Sell	2,796,513 -279,394	-9%	-$11.6M	3.92%	5
2024 Q3	$120M	Sell	3,075,907 -1,294,117	-30%	-$51.6M	3.51%	4
2024 Q2	$149M	Hold	4,370,024	–	–	4.19%	5
2024 Q1	$110M	Hold	4,370,024	–	–	3.02%	7
2023 Q4	$129M	Hold	4,370,024	–	–	3.23%	6
2023 Q3	$138M	Buy	+4,370,024	New	+$120M	3.72%	5
2022 Q1	–	Sell	-435,936	Closed	-$6.95M	–	83
2021 Q4	$6.95M	Hold	435,936	–	–	0.25%	61
2021 Q3	$8.68M	Buy	+435,936	New	+$7.09M	0.34%	57

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc's MIRM Position: Q1 2026 in Review

BVF Inc increased its Mirum Pharmaceuticals (MIRM) stake by 6% in Q1 2026, buying an estimated $8.41M and bringing the position to 1,584,727 shares worth $146M. The position accounts for 4.66% of the portfolio, ranked #6.

BVF Inc first reported a position in MIRM in Q3 2021 and has held it in 13 quarters since. The position peaked at $149M in Q2 2024. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

BVF Inc held 1,584,727 shares of Mirum Pharmaceuticals worth $146M as of Q1 2026.
BVF Inc bought 89,437 Mirum Pharmaceuticals shares in Q1 2026, an estimated $8.41M.
Mirum Pharmaceuticals made up 4.66% of BVF Inc's portfolio in Q1 2026, its #6 holding.
BVF Inc first reported a position in Mirum Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
BVF Inc's Mirum Pharmaceuticals position peaked at $149M in Q2 2024.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.